News & Resources - Johns Hopkins Coronavirus Resource Center (2024)

The Food and Drug Administration has advised vaccine makers to update their COVID-19 vaccines to also target Omicron.

American children ages 6 months through 4 years recently became eligible to receive coronavirus vaccinations, afterfederal regulators andhealth officials clearedvaccines from Moderna and Pfizer-BioNTech for very young children.

U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match recent changes of the shape-shifting coronavirus.

When the Food and Drug Administration (FDA) meets at the end of June to discuss whether the vaccine should be modified before the likely rollout of more booster shots in the fall, it will have to make decisions without knowing how the virus will continue to change.

A COVID-19 surge is underway that is starting to cause disruptions as the school year wraps up and Americans prepare for summer vacations.

Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday,another step toward shots for the littlest kidspossibly beginning in early summer.

The U.S. has officially surpassed 1 million deaths from COVID-19, according to data Tuesday from John Hopkins University.

Since the Omicron wave crested in January, multiple studies and datasets have demonstrated that the mRNA vaccines are not nearly as effective against this variant as they were against earlier variants or the original virus.